TDDA adds tramadol and fentanyl testing amid rising workplace detections
From March, The Drug Detection Agency (TDDA) will make it easier for New Zealand workplaces to screen for tramadol and fentanyl, two high-risk opioids that pose significant safety concerns in workplaces worldwide. This is the first time in New Zealand that these tests will be incorporated into enhanced oral fluid and urine screening devices instead of needing independent testing strips or other costly devices.
Continue reading